Northwire Canada EditionSaturday, July 18, 2026
Northwire
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%
Earnings

Neupath Health to release Q3 2025 results Nov. 13

NPTH · Price

Executive Summary

  • Neupath Health Inc. will release its financial results for the third quarter of 2025 before market open on Thursday, November 13, 2025.
  • The company will host a live investor webinar featuring CEO Joe Walewicz to discuss the Q3 results, operations, and strategic outlook.
  • The webinar will be hosted by Martin Gagel of Market Radius Research and will include a presentation and Q&A session.

Key Details

  • Reporting Period: Third Quarter 2025.
  • Release Timing: Before market open on Thursday, Nov. 13, 2025.
  • Webinar Host: Martin Gagel, Radius Research (former top-ranked technology analyst).
  • Webinar Date and Time: Thursday, Nov. 13, 2025, at 10 a.m. ET / 7 a.m. PT.
  • Webinar Format: Live presentation and Q&A session with CEO Joe Walewicz.
  • Company Operations: Neupath operates a network of healthcare clinics in Ontario and Alberta focusing on chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services, independent medical assessments, and contract research services to pharmaceutical and biotechnology companies.

Notable Quotes

  • No direct quotes from the CEO or management were included in the release text.
Read the original news release →

More from Neupath Health Inc